Patients with IBD have a higher risk for interstitial lung disease than the general population, with the risk being more ...

In 2021, ATYR completed a phase 1b/2a trial in pulmonary sarcoidosis, and have since started a phase 3 trial. Currently the ...

The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but ...

With significant hedge fund interest and a share price under $10, Gossamer Bio, Inc. (NASDAQ:GOSS) secures a spot on our list ...

Advances in classification and treatment of idiopathic inflammatory myopathies highlight the role of biomarkers, ...

Legionnaires’ disease is a rare condition, and incidence is hard to estimate because diagnosis requires a suspicion of ...

Liquidia Corporation (NASDAQ:LQDA) is one of the 11 Best Short Squeeze Stocks to Buy Now. Price targets raised by analysts ...

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the accumulation of scar tissue in the ...

Discover Insmed's innovative therapies targeting rare diseases, with approvals like Brinsupri boosting potential.

Pune: Infantry soldier Tariq Aziz (30) is set to return to active duty after undergoing a bilateral lung transplant — the ...

FDA designates ifinatamab deruxtecan as a breakthrough therapy for extensive-stage small cell lung cancer, promising improved ...

Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...